{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:43:00Z","timestamp":1786203780943,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,8]]},"DOI":"10.7759\/cureus.114169","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T14:58:57Z","timestamp":1786201137000},"source":"Crossref","is-referenced-by-count":0,"title":["Posterior Reversible Encephalopathy Syndrome (PRES) in an Anuric Patient With a WT1 Mutation and Chronic Renal Graft Failure: A Case Report"],"prefix":"10.7759","author":[{"given":"Charles","family":"Massinon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M","family":"Honor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2025.101022","article-title":"Posterior reversible encephalopathy syndrome in chronic kidney disease: incidence, outcomes, and risk factors in a national cohort","volume":"7","author":"He M","year":"2025","unstructured":"He M, Gillespie A. Posterior reversible encephalopathy syndrome in chronic kidney disease: incidence, outcomes, and risk factors in a national cohort. Kidney Med. 2025, 7:101022. 10.1016\/j.xkme.2025.101022","journal-title":"Kidney Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1590\/1678-4685-JBN-3825","article-title":"Posterior reversible leukoencephalopathy syndrome (PRES) after kidney transplantation: a case report","volume":"40","author":"Davi CB","year":"2018","unstructured":"Davi CB, Moraes BP, Lichtenfels BF, Castro Filho JB, Portal MM, Montenegro RM, Manfro RC. Posterior reversible leukoencephalopathy syndrome (PRES) after kidney transplantation: a case report. J Bras Nefrol. 2018, 40:91-4. 10.1590\/1678-4685-JBN-3825","journal-title":"J Bras Nefrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12245-026-01138-9","article-title":"Posterior reversible encephalopathy syndrome (PRES): a narrative review of pathophysiology, clinical insights, and advances in management","volume":"19","author":"Mourid MR","year":"2026","unstructured":"Mourid MR, Oweidat M, Abady E, et al.. Posterior reversible encephalopathy syndrome (PRES): a narrative review of pathophysiology, clinical insights, and advances in management. Int J Emerg Med. 2026, 19:48. 10.1186\/s12245-026-01138-9","journal-title":"Int J Emerg Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2021-003194","article-title":"Posterior reversible encephalopathy syndrome (PRES): diagnosis and management","volume":"22","author":"Triplett JD","year":"2022","unstructured":"Triplett JD, Kutlubaev MA, Kermode AG, Hardy T. Posterior reversible encephalopathy syndrome (PRES): diagnosis and management. Pract Neurol. 2022, 22:183-9. 10.1136\/practneurol-2021-003194","journal-title":"Pract Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00111-8","article-title":"Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions","volume":"14","author":"Fugate JE","year":"2015","unstructured":"Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015, 14:914-25. 10.1016\/S1474-4422(15)00111-8","journal-title":"Lancet Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2017.10.017","article-title":"Posterior reversible encephalopathy syndrome in kidney disease","volume":"3","author":"Ganesh K","year":"2018","unstructured":"Ganesh K, Nair RR, Kurian G, Mathew A, Sreedharan S, Paul Z. Posterior reversible encephalopathy syndrome in kidney disease. Kidney Int Rep. 2018, 3:502-7. 10.1016\/j.ekir.2017.10.017","journal-title":"Kidney Int Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000381316","article-title":"Posterior reversible encephalopathy syndrome in end-stage kidney disease: not strictly posterior or reversible","volume":"41","author":"Canney M","year":"2015","unstructured":"Canney M, Kelly D, Clarkson M. Posterior reversible encephalopathy syndrome in end-stage kidney disease: not strictly posterior or reversible. Am J Nephrol. 2015, 41:177-82. 10.1159\/000381316","journal-title":"Am J Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8377-8","article-title":"Posterior reversible encephalopathy syndrome","volume":"264","author":"Fischer M","year":"2017","unstructured":"Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol. 2017, 264:1608-16. 10.1007\/s00415-016-8377-8","journal-title":"J Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-18081-1_56","article-title":"Understanding posterior reversible encephalopathy syndrome","author":"Legriel S","year":"2011","unstructured":"Legriel S, Pico F, Azoulay E. Understanding posterior reversible encephalopathy syndrome. Annual Update in Intensive Care and Emergency Medicine. Vincent JL (ed): Springer, Berlin, Heidelberg; 2011. 631-53. 10.1007\/978-3-642-18081-1_56"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6852","article-title":"The Wilms' tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression","volume":"5","author":"Wagner KD","year":"2014","unstructured":"Wagner KD, Cherfils-Vicini J, Hosen N, et al.. The Wilms' tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression. Nat Commun. 2014, 5:5852. 10.1038\/ncomms6852","journal-title":"Nat Commun"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.10.016","article-title":"WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing","volume":"20","author":"Amin EM","year":"2011","unstructured":"Amin EM, Oltean S, Hua J, et al.. WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing. Cancer Cell. 2011, 20:768-80. 10.1016\/j.ccr.2011.10.016","journal-title":"Cancer Cell"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.0284-17","article-title":"Posterior reversible encephalopathy syndrome after a variety of combined chemotherapies containing bevacizumab for metastatic colon cancer","volume":"57","author":"Katada E","year":"2018","unstructured":"Katada E, Mitsui A, Sasaki S, Uematsu N, Anan C. Posterior reversible encephalopathy syndrome after a variety of combined chemotherapies containing bevacizumab for metastatic colon cancer. Intern Med. 2018, 57:2403-7. 10.2169\/internalmedicine.0284-17","journal-title":"Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.809962","article-title":"The Wilms tumor gene wt1a contributes to blood-cerebrospinal fluid barrier function in zebrafish","volume":"9","author":"Hopfenm\u00fcller VL","year":"2021","unstructured":"Hopfenm\u00fcller VL, Perner B, Reuter H, Bates TJ, Gro\u00dfe A, Englert C. The Wilms tumor gene wt1a contributes to blood-cerebrospinal fluid barrier function in zebrafish. Front Cell Dev Biol. 2021, 9:809962. 10.3389\/fcell.2021.809962","journal-title":"Front Cell Dev Biol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000353731","article-title":"Posterior reversible encephalopathy syndrome: a noteworthy syndrome in end-stage renal disease patients","volume":"123","author":"Ermeidi E","year":"2013","unstructured":"Ermeidi E, Balafa O, Spanos G, Zikou A, Argyropoulou M, Siamopoulos KC. Posterior reversible encephalopathy syndrome: a noteworthy syndrome in end-stage renal disease patients. Nephron Clin Pract. 2013, 123:180-4. 10.1159\/000353731","journal-title":"Nephron Clin Pract"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00071","article-title":"Posterior reversible encephalopathy syndrome: clinical features and outcome","volume":"11","author":"Hinduja A","year":"2020","unstructured":"Hinduja A. Posterior reversible encephalopathy syndrome: clinical features and outcome. Front Neurol. 2020, 11:71. 10.3389\/fneur.2020.00071","journal-title":"Front Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/505849-posterior-reversible-encephalopathy-syndrome-pres-in-an-anuric-patient-with-a-wt1-mutation-and-chronic-renal-graft-failure-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T14:58:58Z","timestamp":1786201138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/505849-posterior-reversible-encephalopathy-syndrome-pres-in-an-anuric-patient-with-a-wt1-mutation-and-chronic-renal-graft-failure-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.114169","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,8]]}}}